selective cyclooxygenase 2 inhibitor 选择性环氧合酶抑制剂
A selective cyclooxygenase-2 inhibitor, celecoxib, is the only NSAID approved by the Food and Drug Administration for the treatment of familial adenomatous polyposis(FAP) patients.
选择性COX-2抑制剂—塞来昔布是唯一被美国食品和药品管理局(FDA)批准用于家族性多发性腺癌(FAP)患者的非甾体抗炎药。
参考来源 - 玻璃体内注射环氧化酶·2,447,543篇论文数据，部分数据来源于NoteExpress
Diaryl 1, 2, 4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor.
用作高选择性环加氧酶- 2抑制剂的二芳基1,2,4 -三唑衍生物。
Objective:To investigate the change of inflammation marker in the development of rats with pressure overloaded hypertrophy myocardium and influence of selective cyclooxygenase-2 inhibitor.
目的：观察代偿性心脏增大大鼠心肌肥厚过程中各种炎症反应标记物的动态变化及特异性环氧化酶-2抑制剂的影响。
OBJECTIVE: to investigate the preventive effect of celecoxib, a selective cyclooxygenase (cox) - 2 inhibitor, on stomach tumor in rats.
目的：探讨选择性环氧舍酶- 2抑制剂塞来昔布对大鼠胃肿瘤发生的预防作用。
应用推荐